Evidence map›Paper›PMID 28386188›Full record

ArticleSaudi journal of biological sciences2017

Optimizing conditions for calcium phosphate mediated transient transfection.

Ling Guo, Liyang Wang, Ronghua Yang, Rui Feng, Zhongguang Li, Xin Zhou, Zhilong Dong, George Ghartey-Kwansah, MengMeng Xu, Miyuki Nishi and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 47 citations in OpenAlex.

  1. Investigating Dietary microRNA Stability and Function Using a Transgenic Milk Model With Unique microRNA Sequences.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.International journal of molecular sciences · 2021
    Review
  13. Astrocyte Intracellular CaNeurotoxicity research · 2021
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Transfection ofDevelopment (Cambridge, England) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Ling GuoCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Liyang WangCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Ronghua YangCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Rui FengCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Zhongguang LiCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Xin ZhouCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Zhilong Dong2nd Hospital, Lanzhou University, Lanzhou, China.
George Ghartey-KwansahCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
MengMeng XuMedical Scientist Training Program, Duke University Medical Center, USA.
Miyuki NishiSchool of Pharmacology, Kyoto University, Japan.
Qi ZhangCollege of Chemistry and Materials, Shaanxi Normal University, Xi'an 710062, China.
Williams IsaacsSchool of Medicine, Johns Hopkins University, USA.
Jianjie MaSchool of Medicine, Ohio State University, USA.
Xuehong XuCollege of Life Science, Shaanxi Normal University, Xi'an 710062, China.
Shaanxi Normal University · CNDuke Medical Center · USJohns Hopkins Medicine · USKyoto University · JPLanzhou University · CNThe Ohio State University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM145449
6 · The paper itself

Abstract

backgroundCalcium phosphate mediated transfection has been used for delivering DNA into mammalian cells in excess of 30 years due to its most low cost for introducing recombinant DNA into culture cells. However, multiple factors affecting the transfect efficiency are commonly recognized meanwhile for years, the low transfection efficiency of this approach on higher differentiated and non-tumor cells such as CHO and C2C12 limits its application on research.

resultsIn this paper, we systematically evaluated the possible factors affecting the transfection rate of this approach. Two categories, calcium phosphate-DNA co-precipitation and on-cell treatments were set for optimization of plasmid DNA transfection into CHO and C2C12 cell-lines. Throughout experimentation of these categories such as buffer system, transfection media and time, glycerol shocking and so on, we optimized the best procedure to obtain the highest efficiency ultimately. During calcium phosphate DNA-precipitation, the transfection buffer is critical condition optimized with HBS at pH 7.10 (

conclusionsCalcium phosphate mediated transfection is the most low-cost approach to introduce recombinant DNA into culture cells. However, the utility of this procedure is limited in highly-differentiated cells. Here we describe the specific HBS-buffered saline, PH, glycerol shock, vortex strength, transfection medium, and particle concentrations conditions necessary to optimize this transfection method in highly differentiated cells.

Indexed as

C2C12, mouse myoblast cellsCalcium phosphate transfectionCHO, Chinese hamster ovary cellsCo-precipitationFBS, fetal bovine serumIntDen, integrated densityPEG, polyethylene glycolPen-Strep, penicillinstreptomycinTransfection efficiency

Identifiers

PMID28386188
PMCPMC5372392
OpenAlexW2587638077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.